Decoy Therapeutics regains Nasdaq minimum bid price compliance after reverse split

Decoy Therapeutics Inc.

Nasdaq confirmed compliance on March 31, 2026; Common Stock bid price closed at $7.47 on March 20, 2026.
Reverse stock split effective March 6, 2026, to cure bid price deficiency below $1.00.
Company subject to Mandatory Panel Monitor until March 31, 2027; future non-compliance may trigger delisting.
Hearings Panel granted exception until March 20, 2026; compliance achieved with 10 consecutive days above $1.00.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-139145
form_type: 8-K
ticker: DCOY
cik: 0001615219
company_name: Decoy Therapeutics Inc.
filed_at: 2026-04-02T23:59:59+00:00
discovered_at: 2026-05-14T18:02:32.595033+00:00
generated_at: 2026-05-15T07:50:46.113034+00:00
sec_items: ["8.01", "9.01"]
event_type: regulatory
sentiment: positive
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-139145
json_url: https://secwatch.observer/filing/0001193125-26-139145.json
markdown_url: https://secwatch.observer/filing/0001193125-26-139145.md
text_url: https://secwatch.observer/filing/0001193125-26-139145.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1615219/000119312526139145/0001193125-26-139145-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1615219/000119312526139145/dcoy-20260331.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-139145

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.